SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (6875)8/12/2002 12:15:17 PM
From: Biomaven  Read Replies (3) | Respond to of 52153
 
<CRXA>

Interesting - looks like some of the funds that normally make private company investments are going with a beaten-down public company instead.

The Bexxar AC briefing document that hopefully we will see this year is going to make very interesting reading indeed.

Peter



To: Vector1 who wrote (6875)8/12/2002 6:14:11 PM
From: LLCF  Read Replies (1) | Respond to of 52153
 
<For an additional $.125 per underlying share, the investors will also purchase approximately 1.2 million five-year warrants for common stock with an exercise price of $6.13. >

I recon these are worth $3 bucks no????

DAK


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News